뒤로
Aspira Women's Health Inc(AWHL) 가격
AWHL 주가 차트
AWHL 수입
Aspira Women's Health Inc
$0.45
-9.99%
$-0.04
오늘 기준:Jan 23, 13:21:14 GMT-5
최신 수익 결과: Q3 '24
보고됨: 2024-11-19
역사적 수익
분기별
연간
EPS
수익
Earnings FAQ
AWHL의 최근 주당순이익(EPS)은 예상과 비교하여 어떤가요?
Aspira Women's Health Inc AWHL의 지난 분기 매출 실적은 어땠나요?
Aspira Women's Health Inc의 매출 추정치는 얼마인가요?
Aspira Women's Health Inc의 수익 품질 점수는 얼마인가요?
Aspira Women's Health Inc는 언제 수익을 보고하나요?
Aspira Women's Health Inc의 예상 수익은 얼마인가요?
Aspira Women's Health Inc은 수익 기대치를 충족했나요?
주요 통계
이전 종가
$0.5
시가
$0.48
일일 범위
$0.4 - $0.5011
52주 범위
$0.02 - $0.71
거래량
--
평균 거래량
66.5K
EPS(TTM)
-0.99
배당수익률
--
시가총액
$19.1M
AWHL란 무엇인가요?
Aspira Women's Health, Inc. engages in the provision of bio-analytic and diagnostic services. The company is headquartered in Austin, Texas and currently employs 66 full-time employees. The company went IPO on 2000-09-29. The firm's portfolio includes OvaWatch and the Ova1Plus workflow, offered to clinicians as OvaSuite. OvaWatch is used to assess ovarian cancer risk for women with an adnexal mass where their initial clinical assessment indicates the mass is indeterminate or benign. The Ova1Plus is a reflex process of two tests, Ova1 and Overa, to assess the risk of ovarian malignancy in women with an adnexal mass planned for surgery. Its product pipelines are OVAinform and ENDOinform. OVAinform is a test that combines serum proteins, clinical data (metadata), and miRNA for assessing the risk of ovarian cancer in women with an adnexal mass. ENDOinform is a test program that combines serum proteins, clinical data (metadata), and miRNA for the identification of endometriosis.